European Wax Center (EWCZ) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
13 May, 2026Executive summary
Delivered approximately 23 million waxing services in both 2025 and 2024, with system-wide sales of $228.9 million for the quarter, up 1.3% year-over-year.
Operated 1,044 centers at quarter-end, with a net decrease of 3 centers during the period.
Completed a merger on May 8, 2026, resulting in a cash-out transaction for shareholders at $5.80 per Class A share.
Financial highlights
Total revenue for the quarter was $51.1 million, down 0.6% from $51.4 million year-over-year.
Net income attributable to the company was $0.96 million, a 44.7% decrease from $1.74 million in the prior year.
EBITDA was $14.6 million and Adjusted EBITDA was $17.4 million, both down from the prior year.
Cash and cash equivalents stood at $71.7 million as of April 4, 2026.
Outlook and guidance
Management expects continued focus on improving existing center productivity and unit economics, with thoughtful center growth in the future.
Liquidity and capital resources are expected to be sufficient for at least the next twelve months.
Latest events from European Wax Center
- Merger agreement proposal approved by majority vote; final results to be filed with the SEC.EWCZ
AGM 2026 - Stockholders will vote on mergers with General Atlantic affiliates, with board support and added disclosures.EWCZ
Proxy filing - Merger participants will exchange units for $5.80/share and gain rights under the Tax Receivable Agreement.EWCZ
Proxy filing - Shareholders to vote on a $5.80-per-share cash merger, taking the company private at a 48% premium.EWCZ
Proxy filing - Shareholders to vote on $5.80/share going-private merger; Special Committee recommends approval.EWCZ
Proxy filing - Shareholders to vote on $5.80-per-share cash merger, taking company private at a 48% premium.EWCZ
Proxy Filing - Revenue and net income declined in 2025; company to go private with no 2026 guidance.EWCZ
Q4 2025 - Q3 revenue was flat, net income fell, and share repurchases and control weaknesses were reported.EWCZ
Q3 2024 - Adjusted EBITDA up, net income down, 2025 outlook steady amid center closures.EWCZ
Q1 2025